{"id":3383,"date":"2023-10-16T05:26:14","date_gmt":"2023-10-16T05:26:14","guid":{"rendered":"https:\/\/immune.hku.hk\/research-publications\/research-articles\/"},"modified":"2023-11-16T08:49:26","modified_gmt":"2023-11-16T08:49:26","slug":"research-articles","status":"publish","type":"page","link":"https:\/\/immune.hku.hk\/en\/research-publications\/research-articles\/","title":{"rendered":"Research Articles"},"content":{"rendered":"

1. A Framework on Developing an Integrative Medicine Clinical Practice Guideline (CPG) for SLE with Comorbidities Management in Hong Kong<\/span>
\nChen Y, Li PH<\/b>, Zhang C, Wang N, Lau CS, Feng Y.
\nUnder review<\/i><\/span><\/p>\n

2. Uncovering the True Burden of Hereditary Angioedema:\u00a0 <\/span>A Focus on the Asia-Pacific Region<\/span>
\nHonda D, Li PH<\/b>, Jindal AK, Katelaris CH, Zhi YX, Thong BY, Longhurst H.
\nUnder review<\/i><\/span><\/p>\n

3. Epidemiology, outcomes and disproportionate burden of food-dependent exercise-induced anaphylaxis from the Hong Kong Multidisciplinary Anaphylaxis Management Initiative (HK-MAMI)
\n<\/span>Chiang V, Mak HWF, Yeung MHY, Kan AKC, Au EYL, Li PH<\/b>.
\nJ Allergy Clin Immunol Global. (Accepted \u2013 in press)<\/i><\/span><\/p>\n

4. RIsk and Factors associated with disease manifestations in systemic Lupus Erythematosus \u2013 Lupus Nephritis (RIFLE-LN): a ten-year risk prediction strategy derived from a cohort of 1652 patients<\/span>
\nChan SWC, Wang Y, Yap DYH, Chan TM, Lau YL, Lee PPW, Lai WM, Ying SKY, Tse NKC, Leung AMH, Mok CC, Lee KL, Li TWL, Tsang HHL, Yeung WWY, Ho CTK, Wong RWS, Yang W, Lau CS, Li PH<\/b>.
\nFront Immunol. <\/i>2023 14:1200732. doi: 10.3389\/fimmu.2023.1200732<\/span><\/p>\n

5. Inactivated COVID-19 vaccines: potential concerns of antibody-dependent enhancement and original antigenic sin<\/span>
\nKan AKC, Li PH<\/b>.
\nImmunol Lett. <\/i>2023 Jul; 259: 21\u201323. doi: 10.1016\/j.imlet.2023.05.007. <\/span><\/p>\n

6. Waning effectiveness against COVID-19-related hospitalisation, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case-control study<\/span>
\nYan VKC,<\/span> Wan EYF, Ye X, Mok AHY, Lai FTT, Chui CSL, Li X, Wong CKH, Li PH<\/b>, Ma T, Qin S, Lau CS, Wong ICK, Chan EWY.
\nEmerg Microbes Infect. <\/i>2023 Dec;12(1):2209201. doi: 10.1080\/22221751.2023.2209201.<\/span><\/p>\n

7. Prospective Assessment of Penicillin Allergy (PAPA): Evaluating the performance of penicillin allergy testing and post-delabelling outcomes among Hong Kong Chinese
\n<\/span>Li TS, Hui HKS, Kan AKC, Yeung MHY, Wong JCY, Chiang V, Li PH<\/b>.
\nAsian Pac J Allergy Immunol. <\/i>2023 Apr 17. doi: 10.12932\/AP-270922-1469.
\n<\/span><\/p>\n

8. COVID-19 in the Asia Pacific: impact on climate change, allergic diseases and One Health
\n<\/span>Pawankar R, Thong BY, Recto M, Wang JY, Latiff AHA, Leung TF, Li PH<\/b>, Lobo RCM, Lucas M, Oh JW, Kamchaisatian W, Nagao M, Rengganis I, Udwadia ZF, Dhar R, Munkhbayarlakh S, Naratestseg L, Pham DL, Zhang Y, Zhang L.
\nAsia Pac Allergy<\/i>. 2023 13(1): 44-49, Mar. doi: 10.5415\/apallergy.0000000000000021.<\/span><\/p>\n

9. Validation of the Chinese Drug Hypersensitivity Quality of Life Questionnaire: Role of delabelling
\n<\/span>Mak HWF, Chan ETS, Yim JSH, Lee E, Lam DLY, Chiang V, Li PH<\/b>.
\nAsia Pac Allergy<\/i>. 2023 <\/i>13(1): 3-9, Mar. doi: 10.5415\/apallergy.0000000000000020.<\/span><\/p>\n

10. Epidemiology and risk factors for Carbapenemase-Producing Enterobacteriaceae carriage in the hospital: a population-based nested case-control study<\/span><\/p>\n

Fan M, Wong S, Yu Q, Li PH<\/b>, Wu P, Chan EWY, Wong ICK, Tun HM, Cowling BJ, Cheng VCC, Chui CSL.
\nJ Glob Antimicrob Resist. <\/i>2023. doi: 10.1016\/j.jgar.2023.03.013.<\/span><\/p>\n

11. Disparities and inequalities of penicillin allergy in the Asia-Pacific region
\n<\/span>Li PH<\/b>, Pawankar R, Thong BYH, Mak HWF, Chan G, Chung W, Juan M, Kang H, Kim B, Lobo RCM, Lucas M, Pham DL, Ranasinghe T, Rengganis I, Rerkpattanapipat T, Sonomjamts M, Tsai Y, Wang JY, Yamaguchi M, Yun J.
\nAllergy. <\/i>2023 Mar 23. doi: 10.1111\/all.15725. <\/span><\/p>\n

12. Adult-onset Still\u2019s disease after mRNA COVID-19 vaccination presenting with severe myocarditis with acute heart failure and cardiogenic shock: a case report
\n<\/span>Kan AKC, Yeung WYW, Lau CS, Li PH<\/b>.
\nHong Kong Med J. <\/i>2023;29. doi: 10.12809\/hkmj2210110.
\n<\/i><\/span><\/p>\n

13. Effectiveness of molnupiravir and nirmatrelvir-ritonavir in hospitalized COVID-19 patients: A Target Trial Emulation Study
\n<\/span>Wan EYK, Yan VKC, Mok AHY, Wang B, Xu W, Cheng FWT, Lai FTT, Chui CSL, Li X, Wong CKH, Li PH<\/b>, Cowling BJ, Hung IFN, Lau CS, Wong ICK, Chan EWY.
\nAnn Intern Med.<\/i><\/span> 2023 Mar 14. doi: 10.7326\/M22-3057.<\/span><\/p>\n

14. Delabelling Multiple Antibiotic Allergy: Practical Issues<\/span>
\nLi PH<\/b>, Thong BYH.
\nFront Allergy. <\/i>2023 doi: 10.3389\/falgy.2023.1156137.<\/span><\/p>\n

15. Molnupiravir and nirmatrelvir-ritonavir reduce mortality risk during post-acute COVID-19 phase<\/span>
\nWan EYF, Wan B, Mathur S, Chan CIY, Yan VKC, Lai FTT, Chui CSL, Li X, Wong CKH, Li PH<\/b>, Lau CS, Wong ICK, Chan EWY.
\nJ Infect. <\/i>2023 Feb 21;S0163-4453(23)00117-2. doi: 10.1016\/j.jinf.2023.02.029.<\/span><\/p>\n

16. Ten-year outcomes of Perioperative Anaphylaxis Workup Study in Hong Kong (PAWS-HK): comparative performance between different diagnostic modalities and a female predominance for suxamethonium anaphylaxis
\n<\/span>Au EYL, Mak HWF, Yeung MHY, Chiang V, Lam K, Wong JCY, Yeung HHY, Chan EYT, Lau CS, Li PH<\/b>.
\nAllergy Asthma Immunol Res.<\/i> 2023 Feb 24;S1081-1206(23)00125-4. doi: 10.1016\/j.anai.2023.02.017.<\/span><\/p>\n

17. A case of persistent IgE sensitisation almost two decades following ampicillin anaphylaxis
\n<\/span>Au EYL, Chiang V, Kan AKC, Lam K, Wong JCY, Yeung HHY, Li PH<\/b>.
\nAllergol Immunopathol (Madr). <\/i>2023;51(2):126\u2013129. doi: 10.15586\/aei.v51i2.748.<\/span><\/p>\n

18. Booster vaccination with inactivated or messenger RNA vaccines and COVID-19-related mortality in individuals with multimorbidity amid the Omicron epidemic: a retrospective cohort study
\n<\/span>Lam FTT, Yan VKC, Ye X, Ma T, Qin X, Chiu CSL, Li X, Wan EYF, Wong CKH, Cheung CL, Li PH<\/b>, Cheung BMY, Lau CS, Wong ICK, Chan EWY.
\nCMAJ <\/i>2023 Jan 30;195(4):E143-E152. doi: 10.1503\/cmaj.221068.<\/span><\/p>\n

19. Antibiotic Allergy in Hong Kong
\n<\/span>Chiang V, Yeung M, Li PH<\/b>.
\nHK Pract. <\/i>2022 <\/i>44:98-105 <\/span><\/p>\n

20. Epidemiology, management and treatment access of hereditary angioedema in the Asia Pacific Region: outcomes from an international survey
\n<\/span>Li PH<\/b>, Pawankar R, Thong BYH, Fok JS, Chantaphakul H, Hide M, Jindal AK, Kang H, Latiff AHA, Lobo RC, Sonomjamts M, Nguyen VD, Shyur S, Zhi Y, Maurer M.
\nJ Allergy Clin Immunol Pract. <\/i>2023 doi: 10.1016\/j.jaip.2022.12.021.<\/span><\/p>\n

21. COVID-19 Vaccine Allergy Safety Track (VAS-Track) pathway: real-world outcomes on vaccination rates and antibody protection
\n<\/span>Chiang V, To KWK, Saha C, Yim SH, Wong JCY, Au, EYL, Kan AKC, Hong YD, Ye J, Ng CS, Ho TKC, Lau CS, Lam TTY, Chan EWY, Quan J, Li PH<\/b>.
\nAsian Pac J Allergy Immunol. <\/i>2023 <\/i>doi: 10.12932\/AP-110722-1410.<\/span><\/p>\n

22. Chronic spontaneous urticaria in Hong Kong: clinical characteristics, real-world practice and implications for COVID-19 vaccination<\/span><\/p>\n

Kan AKC, Wong TTH, Chiang V, Lau CS, Li PH<\/b>.<\/span><\/p>\n

Allergy Asthma Immunol Res<\/i>. 2023 Jan;15(1):32-42. doi: 10.4168\/aair.2023.15.1.32<\/span><\/p>\n

23. Ten-year population trends of immunoglobulin use, burden of adult antibody deficiency and feasibility of subcutaneous immunoglobulin (SCIg) replacement in Hong Kong Chinese
\n<\/span>Kan AKC, Leung GMK, Chiang V, Au EYL, Lau CS, Li PH<\/b>.
\nFront Immunol. <\/i>2022 13:984110. doi: 10.3389\/fimmu.2022.984110.<\/span><\/p>\n

24. Differences in Beta-Lactam and Penicillin Allergy: Beyond the West and Focusing on the Asia-Pacific
\n<\/span>Mak HWF, Yeung MHY, Wong JCY, Chiang V, Li PH<\/b>.
\nFront. <\/i>Allergy 2022 3:1059321. doi: 10.3389\/falgy.2022.1059321.<\/span><\/p>\n

25. Disproportionate rate of female referrals for suspected COVID-19 vaccine allergies
\n<\/span>Chiang V, Kan AKC, Yim JSH, Lee E, Au EYL, Li PH<\/b>.
\nAllergy <\/i>2022 Sep 20;10.1111\/all.15522. doi: 10.1111\/all.15522.<\/span><\/p>\n

26. Emergency Management of Food-Induced Anaphylaxis and Severe Reactions in Young Infants<\/span><\/p>\n

Hon KL, Tan YW, Leung KKY, Fung GPG, Li PH<\/b>.<\/span><\/p>\n

Curr Pediatr Rev. <\/i>2022 Oct 27. doi: 10.2174\/1573396319666221027115126.<\/span><\/p>\n

27. Comparative effectiveness, safety and real-world outcomes of a nurse-led, protocol-driven penicillin allergy evaluation from the Hong Kong Drug Allergy Delabelling Initiative (HK-DADI)
\n<\/span>Kan AKC, Hui HKS, Li TS, Chiang V, Wong JCY, Chan TS, Kwan IYK, Shum WZ, Yeung MSC, Au EYL, Ho CTK, Lau CS, Li PH<\/b>.
\nJ Allergy Clin Immunol Pract. <\/i>2022 Sep 17 <\/i>doi: 10.1016\/j.jaip.2022.08.052.<\/span><\/p>\n

28. Hong Kong Drug Allergy Delabelling Initiative (HK-DADI) Consensus Statements for Penicillin Allergy Testing by Non-Allergists
\n<\/span>Li PH<\/b>, Wong JCY, Chan JMC, Chik TSH, Chu MY, Ho GCH, Leung WS, Li TCM, Ng YY, Shum R, Sin WWY, Tso EYK, Wu AKL, Au EYL.
\nFront Allergy. <\/i>2022 <\/i>3:974138. doi: 10.3389\/falgy.2022.974138.<\/span><\/p>\n

29. Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case-control study <\/span><\/p>\n

Yan VKC, Wan EYF, Ye CX, Mok AHY, Lai FTT, Chui CSL, Li X, Wong CKH, Li PH<\/b>, Ma T, Qin S, Wong VKC, Tsang TC, Tsui SH, Chui WCM, Cowling BJ, Leung GM, Lau CS, Wong ICK, Chan EWY. \u00a0 <\/span>
\nEmerg Microbes Infect.<\/i> 2022 Aug 18;1-48. doi: 10.1080\/22221751.2022.2114854.<\/span><\/p>\n

30. Prevalence and real-life impact of misdiagnosed drug allergy labels among patients with hereditary angioedema
\n<\/span>Cheong N, Wong JCY, Kan AKC, Lau CS, Li PH<\/b>.
\nFront Allergy. <\/i>2022 3:953117. doi: 10.3389\/falgy.2022.953117.<\/span><\/p>\n

31. Prospective study on the efficacy and impact of Cascade Screening and Evaluation of HAE (CaSE-HAE)
\n<\/span>Wong JCY, Chiang V, Lam K, Tung E, Au EYL, Lau CS, Li PH<\/b>.
\nJ Allergy Clin Immunol Pract.<\/i> 2022 Aug 11 doi: 10.1016\/j.jaip.2022.07.035.<\/span><\/p>\n

32. Asia-Pacific Perspectives on the Second Year of the COVID-19 Pandemic: A Follow-up Survey
\n<\/span>Pawankar R, Thong B, Tiongco-Recto M, Wang JY, Latiff AHA, Leung TF, Li PH<\/b>, Lobo RCM., Lucas M, Jae-won O, Kamchaisatian W, Nagao M, Rengganis I, Udwadia ZF, Dhar R, Munkhbayarlakh S, Narantsetseg L, Pham D, Zhang Y, Zhang L.
\nClin Exp Allergy. <\/i>2022; 52: 965- 973. doi: 10.1111\/cea.14191.<\/span><\/p>\n

33. Under-awareness and over-diagnosis of COVID19 vaccine \u201callergy\u201d<\/span><\/p>\n

Chiang V, Chan TS, Lau CS, Li PH<\/b>.
\nContact Dermatitis <\/i>2022 Jul 25. doi: 10.1111\/cod.14193.<\/span><\/p>\n

34. Sensitisation Profile of Chinese Allergic Rhinitis Patients and Effectiveness of a Joint Allergy-ENT Clinic<\/span><\/p>\n

Hui KSH, Li TS, Lo WLW, Kan AKC, Ho SY, Yeung WYW, Wong JCY, Chiang V, Wong BYH, Li PH<\/b>.<\/span>
\n<\/b><\/span>Allergo J Int. <\/i>2022 Jul 7;1-9. doi: 10.1007\/s40629-022-00218-5.<\/span><\/p>\n

35. The Role of the Allergist in COVID-19 Vaccine Allergy Safety: A Pilot Study on a \u201cHub-and-Spoke\u201d Model for Population-Wide Allergy Service
\n<\/span>Chiang V, Saha C, Yim SH, Au EYL, Hui KSH, Li TS, Lo WLW, Hong YD, Ye J, Ng CS, Ko WWK, Ho CTK, Lau CS, Quan J, Li PH<\/b>.
\nAnn Allergy Asthma Immunol. <\/i>2022. doi: 10.1016\/j.anai.2022.05.011.<\/span><\/p>\n

36. Polyethylene glycol allergy: risks of skin testing and complement mediated anaphylaxis
\n<\/span>Chiang V, Kan AKC, Yeung HHY, Au EYL, Lau CS, Li PH<\/b>.
\nJ Investig Allergol Clin Immunol. <\/i>2022 Apr 7. doi: 10.18176\/jiaci.0813.<\/span><\/p>\n

37. Novel MAGT1 Mutation Found in the First Chinese XMEN in Hong Kong
\n<\/span>Au EYL, Tung EKK, Ip RWK, Li PH<\/b>.
\nCase Reports Immunol. <\/i>2022 2390167. doi: 10.1155\/2022\/2390167. <\/span><\/p>\n

38. Delayed-type drug eruption to phenazopyridine (Pyridium) confirmed with patch testing
\n<\/span>Yeung WY, Wong SM, Leung WY, Li PH<\/b>.
\nAsia Pac Allergy. <\/i>2022 Jan;12(1):e10. doi: 10.5415\/apallergy.2022.12.e10.<\/span><\/p>\n

39. Updated Consensus Statements on COVID19 Vaccine Allergy Safety in Hong Kong
\n<\/span>Chiang V, Leung AS, Ho MH, Au E, Lee TH, Wu AY, Wong GWK, Li PH.<\/b>
\nAsia Pac Allergy <\/i>2022 Jan;12(1):e8. doi: 10.5415\/apallergy.2022.12.e8.<\/span><\/p>\n

40. Importance of challenging and updating allergy skin test concentrations
\n<\/span>Chiang V, Mong PKP, Chan KKE, Au YLE, Li PH<\/b><\/span>.
\n<\/i><\/span>Contact Dermatitis. <\/i>2021 Dec 7.<\/i> doi: 10.1111\/cod.14023.<\/span><\/p>\n

41. Long-term results of triple immunosuppression with tacrolimus added to mycophenolate and corticosteroids in the treatment of lupus nephritis
\n<\/span>Yap YHD*, Li PH<\/b>*, Tang C, So YFB, Kwan PYL, Chan CWG, Lau CS, Chan TM.
\nKidney International Reports <\/i>2022; <\/i>doi: 10.1016\/j.ekir.2021.12.005.
\n<\/i><\/span><\/p>\n

42. Experience of the first 1127 COVID-19 Vaccine Allergy Safety patients in Hong Kong \u2013 clinical outcomes, barriers to vaccination and urgency for reform
\n<\/span>Chiang V, Mok WSS, Chan KCJ, Leung WY, Ho TKC, Au YLE, Lau CS, Lee TH, Li PH<\/b><\/span>.
\n<\/i><\/span>World Allergy Organ J . <\/i>2021 <\/i>Dec 20;100622. doi: 10.1016\/j.waojou.2021.100622.
\n<\/span><\/p>\n

43. Caution against injudicious vaccine allergy skin tests: adverse reactions after intradermal COVID-19 vaccine testing
\n<\/span>Chiang V, Mong PKP, Chan KKE, Au YLE, Li PH<\/b><\/span>.
\n<\/i><\/span>Contact Dermatitis. <\/i>2021;1-2. doi: 10.1111\/cod.13977.<\/span><\/p>\n

44. Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci<\/i> pneumonia among rheumatic patients: a territory-wide study
\n<\/span>Chan SCW, Chung HY, Lau CS, Li PH<\/b>.
\nAnn Clin Microbiol Antimicrob<\/i>. 2021 <\/i>20:78. doi: 10.1186\/s12941-021-00483-2.
\n<\/i><\/span><\/p>\n

45. Cardiovascular risk in spondyloarthritis and the effect of anti-TNF drugs
\n<\/span>Chan SCW, Teo KC, Li PH<\/b>, Lau GKK, Lau CS, Chung HY.
\nTher Adv Musculoskelet Dis.<\/i><\/span> Jan. 2021. doi: 10.1177\/1759720X211032444.
\n<\/i><\/span><\/p>\n

46. Caution against temporary tolerance and negative skin testing during anergic period following systemic reactions
\n<\/span>Li PH<\/b>, Chiang V, Yeung HHF, Au EYL.
\nJ Investig Allergol Clin Immunol <\/i>2021 Jul 2;0. doi: 10.18176\/jiaci.0724.
\n<\/i><\/span><\/p>\n

47. Consensus Statements on the Approach to COVID19 Vaccine Allergy Safety in Hong Kong
\n<\/span>Chiang V, Leung AS, Ho MH, Au E, Lee TH, Wu AY, Wong GWK, Li PH.<\/b>
\nFront Allergy. <\/i>2021<\/span> Jul 14;2:690837. doi: 10.3389\/falgy.2021.690837.
\n<\/i><\/span><\/p>\n

48. Drug allergy management in the elderly
\n<\/span>Wong JCY, Li PH<\/b>.
\nCurr Opin Allergy Clin Immunol<\/i>. 2021 Jun 7. doi: 10.1097\/ACI.0000000000000761.
\n<\/i><\/span><\/p>\n

49. First confirmed case of IgE-mediated hypersenstivity to evolucumab with cross reactivity to alirocumab
\n<\/span>Lam SSY, Chiang V, Lam K, Yeung HHY, Au EYL, Li PH<\/b>.
\nJ Allergy Clin Immunol Pract.<\/i> 2021 Jul 2 doi: 10.1016\/j.jaip.2021.06.012.
\n<\/i><\/span><\/p>\n

50. Hong Kong Anaphylaxis Consortium Consensus Statements on Prescription of Adrenaline Autoinjectors
\n<\/span>Li PH<\/b>, Chua GT, Leung ASY, Chan YC, Chan KKL, Cheung KH, Chong PCY, Ho PPK, Kwan MYW, Lai JCH, Lam KK, Lam TSK, Leung TF, Li TY, Rosa Duque JS, So JLT, Wan KA, Wong HCY, Lam EH, Wu AYY, Lee TH, Ho MHK, Siu AYC.
\nAsia Pac Allergy. <\/i>2021 Jan 6;11(1):e1. doi: 10.5415\/apallergy.2021.11.e1.
\n<\/i><\/span><\/p>\n

51. The impact of childhood pneumococcal conjugate vaccine immunisation on all-cause pneumonia admissions in Hong Kong: a 14-year population based interrupted time series analysis
\n<\/span>Yu Q, Li X, Fan M, Qiu H, Wong AYS, Tian L, Chui CSL, Li PH<\/b>, Lau LKW, Chan EW, Goggins WB, Ip P, Lum TY, Hung IFN, Cowling BH, Wong ICK, Jit M.
\nVaccines <\/i>2021 Apr 12;S0264-410X(21)00406-0. doi: 10.1016\/j.vaccine.2021.03.090.
\n<\/i><\/span><\/p>\n

52. Epidemiology and outcomes of geriatric and non-geriatric patients with drug allergy labels in Hong Kong
\n<\/span>Li PH<\/b>, Chung HY, CS Lau.
\nHong Kong Med J. <\/i>2021 Jun;27(3):192-197. doi: 10.12809\/hkmj208716.
\n<\/i><\/span><\/p>\n

53. Behcet\u2019s Disease diagnosed by allergy skin testing and positive pathergy test
\n<\/span>Yeung WWY, Wong SM, Au EYL, Li PH<\/b>.
\nJ Allergy Clin Immunol Pract <\/i>2020 Dec 11;S2213-2198(20)31250-2. doi: 10.1016\/j.jaip.2020.11.029.
\n<\/i><\/span><\/p>\n

54. Piperacillin-tazobactam allergies: an exception to usual penicillin allergy
\n<\/span>Wong JCY, Au EYL, Yeung HHF, Lau CS, Li PH<\/b>.
\nAllergy Asthma Immunol Res. <\/i>2021 Mar;13(2):e26. doi: 10.4168\/aair.2021.13.2.284.
\n<\/i><\/span><\/p>\n

55. Increasing incidence of anaphylaxis in Hong Kong from 2009 to 2019 \u2013 discrepancies of anaphylaxis care between adult and paediatric patients
\n<\/span>Li PH<\/b>, Leung ASY, Li RMY, Leung TF, Lau CS, Wong GWK.
\nClin Transl Allergy <\/i>2020 10:51. doi: 10.1186\/s13601-020-00355-6<\/span>.<\/span>
\n<\/i><\/span><\/p>\n

56. Prevalence and impact of reported drug allergies among rheumatology patients
\n<\/span>Chan SCW, Chung HY, TT Cheung, Chiu ESH, Lee MSH, Lau CS, Li PH<\/b>.
\nDiagnostics (Basel) <\/i>2020 10(11), 918. doi: 10.3390\/diagnostics10110918.<\/span><\/p>\n

57. Diagnostic utility of whole spine and thoracic spine MRI corner inflammatory lesions in axial spondyloarthritis
\n<\/span>Chan SCW, Li PH<\/b>, Lee KH, Tsang HHL, Lau CS, Chung HY.
\nTher Adv Musculoskelet Dis<\/i> 2020 12:1-11. doi: 10.1177\/1759720X20973922.
\n<\/i><\/span><\/p>\n

58. Conventional and biologic disease-modifying anti-rheumatic drugs are not associated with increased cervical neoplasia among patients with spondyloarthritis
\n<\/span>Li PH<\/b>, Chan SCW, Lau CS, Seto MTY, Chung HY.
\nJ Clin Rheumatol. <\/i>2020 Oct 22. doi: 10.1097\/RHU.0000000000001590.
\n<\/i><\/span><\/p>\n

59. Diagnostic Procedures & Practices in Drug Allergy\/Hypersensitivity: A survey of 13 Asian countries
\n<\/span>Tang M, Fok JS, Thong BY, Lucas M, Kang H, Chang Y, Li PH<\/b>, Yun J, Kim B, Nagao M, Rengganis I, Tsai Y, Chung W, Yamaguchi M, Rerkpattanapipat T, Kamchaisatan W, Leung TF, Ho J, Zhang L, Latiff AHA, Fujisawa T, Thien F, Castells MC, Demoly P, Wang JY, Pawankar R.
\nAsia Pac Allergy. <\/i>2020 Oct;10(4):e36. doi: 10.5415\/apallergy.2020.10.e36.
\n<\/span><\/p>\n

60. Skin testing for cross-reactivity between proton pump inhibitors
\n<\/span>Li PH<\/b>.
\nHong Kong Med J. <\/i>2020 Oct;26(5):450.e1\u20132. doi:<\/span> 10.12809\/hkmj198267.
\n<\/i><\/span><\/p>\n

61. Importance of allergological evaluation and skin testing for severe cutaneous adverse reactions
\n<\/span>Li PH,<\/b> Wong JCY, Lau CS.
\nHong Kong Med J. <\/i>2020 Oct;26(5):444\u20135. doi:<\/span> 10.12809\/hkmj198263.<\/span><\/p>\n

62. DRESS syndrome induced by antibiotic-loaded bone cements and a diagnostic algorithm for delayed-type hypersensitivity reactions
\n<\/span>Chiang V, Wong JCY, Yeung HHF, Au EYL, Li PH<\/b>.
\nJ Allergy Clin Immunol Pract<\/i> 2020 Oct 8;S2213-2198(20)31089-8. doi: 10.1016\/j.jaip.2020.09.040.<\/span><\/p>\n

63. Novel mutations identified in the first Chinese pedigree of complete C6 deficiency
\n<\/span>Li PH,<\/b> Wong WWY, Leung ENY, Lau CS, Au E.
\nClin Transl Immunology <\/i>2020; 9(7): e1148. doi: 10.1002\/cti2.1148.
\n<\/i><\/span><\/p>\n

64. Efficacy and Safety of Vaccinations in Systemic Lupus Erythematosus
\n<\/span>Li PH,<\/b> Lau CS.
\nJournal of Clinical Rheumatology and Immunology<\/i> 2020 Jun;2:1-7. doi: 10.1142\/S2661341720300037.
\n<\/i><\/span><\/p>\n

65. Excipient allergy and importance of complete allergy histories
\n<\/span>Li PH<\/b>, Yeung HHF, Lau CS, Au EYL.
\nJ Allergy Clin Immunol Pract <\/i>2020;8:2122-3. doi: 10.1016\/j.jaip.2020.04.010.
\n<\/i><\/span><\/p>\n

66. Prevalence, Incidence, and Sensitization Profile of \u03b2-lactam Antibiotic Allergy in Hong Kong
\n<\/span>Li PH,<\/b> Yeung HHF, Lau CS, Au EYL.
\nJAMA Netw Open. <\/i>2020 May 1;3(5):e204199. doi: 10.1001\/jamanetworkopen.2020.4199.
\n<\/i><\/span><\/p>\n

67. Drug hypersensitivity reactions in Asia: Regional Issues and Challenges
\n<\/span>Thong BY, Lucas M, Kang H, Chang Y, Li PH<\/b>, Tang M, Yun J, Fok JS, Kim B, Nagao M, Rengganis I, Tsai Y, Chung W, Yamaguchi M, Rerkpattanapipat T, Kamchaisatian W, Leung TF, Yoon HJ, Ho J, Zhang L, Latiff AHA, Fujisawa T, Thien F, Castells MC, Demoly P, Wang JY, Pawankar R.
\nAsia Pac Allergy. <\/i>2020 Jan;10(1):e8. doi: 10.5415\/apallergy.2020.10.e8<\/span>
\n<\/span><\/p>\n

68. Differences in Wheat Dependent Exercise-Induced Anaphylaxis: East vs West
\n<\/span>Li PH,<\/b> Thomas I, Wong JCY, Rutkowski K, Lau CS.
\nAsia Pac Allergy. <\/i>2020 Jan;10(1):e5. doi: 10.5415\/apallergy.2020.10.e5.<\/span><\/p>\n

69. Clinical Associations of Uveitis in Axial Spondyloarthritis Group and Ankylosing Spondylitis Group: Do They Represent the Same Disease?
\n<\/span>Wong OM, Tsang HHL, Chan SCW, Lee KH, Li PH<\/b>, Lau CS, Chung HY.
\nJ Clin Rheumatol<\/i>. 2020 Jan;26(1):1-6. doi: 10.1097\/RHU.0000000000000869.
\n<\/span><\/p>\n

70. Carbamazepine induced B cell aplasia: over-looked and over-treated
\n<\/span>Wong JCY, Li PH<\/b>.
\nAnn Allergy Asthma Immunol. <\/i>2019 Nov 4. pii: S1081-1206(19)31378-X. doi: 10.1016\/j.anai.2019.10.019.
\n<\/span><\/p>\n

71. Beta-lactam allergy in Chinese and factors predicting genuine allergy
\n<\/span>Li PH<\/b>, Siew LQC, Thomas I, Watts TJ, Ue KL, Rutkowski K, Lau CS.
\nWorld Allergy Organ J. <\/i>2019 Sep 16; 12(8): 100048. doi: 10.1016\/j.waojou.2019.100048
\n<\/span><\/p>\n

72. Identifying Low-risk Beta-Lactam allergy Patients in a UK Tertiary Centre
\n<\/span>Siew LQC*, Li PH<\/b>*, Watts TJ, Thomas I, Ue KL, Caballero MR, Rutkowski K, Till SJ, Prathap P, Haque R.
\nJ Allergy Clin Immunol Pract. <\/i>2019 Sep – Oct;7(7):2173-2181.e1. doi: 10.1016\/j.jaip.2019.03.015.\u00a0 <\/span><\/span><\/p>\n

73. Fixed drug eruption to biologics and role of lesional patch testing
\n<\/span>Li PH<\/b>, Watts TJ, Chung HY, Lau CS.
\nJ Allergy Clin Immunol Pract. <\/i>2019 Sep – Oct;7(7):2398-2399. doi: 10.1016\/j.jaip.2019.06.028.<\/span><\/p>\n

74. The association between age and clinical and radiological activity in axial spondyloarthritis
\n<\/span>Li PH<\/b>, Chung HY, Wong CS, Tsang HHL, Lau VWH, Ho G, Xu X, Lau CS, Ma KY.
\nJournal of Clinical Rheumatology and Immunology<\/i> 2019 May;1:1-8. doi: 10.1142\/S2661341719500019.
\n<\/span><\/p>\n

75. Importance of comprehensive allergological workup in corticosteroid allergy
\n<\/span>Li PH<\/b>, Rutkowski K.
\nAsia Pac Allergy. <\/i>2019 Apr 23;9(2):e19. doi: 10.5415\/apallergy.2019.9.e19. <\/i><\/span><\/p>\n

76. Hong Kong Institute of Allergy and Hong Kong Society for Paediatric Immunology Allergy & Infectious Diseases joint consensus statement 2018 on vaccination in egg-allergic patients
\n<\/span>Chua GT, Li PH<\/b>, Ho MHK, Lai E, Ngai V, Yau FYS, Kwan MYW, Leung TF, Lee TH.
\nHong Kong Med J. <\/i>2018 Oct;24(5):527-531. doi: 10.12809\/hkmj177137
\n<\/span><\/p>\n

77. Steroid allergy: Clinical features and the importance of excipient testing in a diagnostic algorithm
\n<\/span>Li PH<\/b>, Thomas I, Watts TJ, Wagner A, Rutkowski R, Rutkowski K.
\nJ Allergy Clin Immunol Pract.<\/i> 2018 Sep – Oct;6(5):1655-1661. doi: 10.1016\/j.jaip.2018.01.007.
\n<\/span><\/p>\n

78. DRESS Syndrome due to benzylpenicillin with cross-reactivity to amoxicillin
\n<\/span>Watts TJ, Li PH<\/b>, Haque R.
\nJ Allergy Clin Immunol Pract.<\/i> 2018 Sep – Oct;6(5):1766-1768. doi: 10.1016\/j.jaip.2018.01.011.
\n<\/span><\/p>\n

79. Chronic mucocutaneous candidiasis \u2013 more than just skin deep
\n<\/span>Li PH<\/b>, Lee PPW, Fung SF, Lau CS, Lau YL.
\nHong Kong Med J.<\/i> 2018 Aug;24(4):423-425. doi: 10.12809\/hkmj166048.
\n<\/span><\/p>\n

80. Diffusion-weighted imaging versus short tau inversion recovery sequence: Usefulness in detection of active sacroiliitis and early diagnosis of axial spondyloarthritis
\n<\/span>Chan CWS, Tsang HHL, Li PH<\/b>, Lee KH, Lau CS, Wong PYS, Chung HY.
\nPLoS One. <\/i>2018 Aug 7;13(8):e0201040. doi: 10.1371\/journal.pone.0201040. <\/span><\/p>\n

81. Challenge-confirmed peanut allergy in older patients: performance of skin tests, specific IgE, Ara h 2
\n<\/span>Li PH<\/b>, Rutkowski K, Kennard L, Sellaturay P, Watts TJ, Haque R, Wagner A.
\nAnn Allergy Asthma Immunol. 2018 Mar;120(3):334-335. doi: 10.1016\/j.anai.2017.12.014.<\/i><\/span><\/p>\n

82. Recall Urticaria in Adalimumab Hypersensitivity
\n<\/span>Li PH<\/b>, Watts TJ, Lui MS, Lau CS, Chung HY.
\nJ Allergy Clin Immunol Pract. <\/i>2018 May – Jun;6(3):1032-1033. doi: 10.1016\/j.jaip.2017.10.03.
\n<\/span><\/p>\n

83. The paradox of anti-histamine hypersensitivity
\n<\/span>Rutkowski K, Li PH<\/b>, Wagner A.
\nJ Allergy Clin Immunol Pract<\/i>. 2018 Jan – Feb;6(1):258-259. doi: 10.1016\/j.jaip.2017.10.035.
\n<\/span><\/p>\n

84. The unmet provision of allergy services in Hong Kong impairs capability for allergy prevention \u2013 implications for the Asia Pacific region
\n<\/span>Lee TH, Leung TF, Wong G, Ho M, Rosa JS, Li PH<\/b>, Lau CS, Lam WF, Wu A, Chan E, Lai C, Lau YL.
\nAsian Pac J Allergy Immunol.<\/i> 2017 Dec 10. doi: 10.12932\/AP-250817-0150.<\/span><\/p>\n

85. Blue dye allergy: Pitfalls in diagnosis and how to avoid them
\n<\/span>Li PH<\/b>, Wagner A, York M, Rutkowski R, Haque R, Rutkowski K.
\nJ Allergy Clin Immunol Pract. <\/i>2018 Jan – Feb;6(1) :272-273. doi: 10.1016\/j.jaip.2017.06.016.
\n<\/span><\/p>\n

86. Chronic Allergic Contact Dermatitis Due to Chlorhexidine
\n<\/span>Watts TJ, Li PH<\/b>, Ue KL, Haque R.
\nJ Allergy Clin Immunol Pract. <\/i>2018 Jan – Feb;6(1):254-255. doi: 10.1016\/j.jaip.2017.08.002.
\n<\/span><\/p>\n

87. An alternative explanation for immediate hypersensitivity reactions to opioids
\n<\/span>Li PH<\/b>, Ue KL, Wagner A, Rutkowski R, Rutkowski K.
\nJ Allergy Clin Immunol Pract. <\/i>2017 Nov – Dec;5(6):1806-1807. doi: 10.1016\/j.jaip.2017.08.015.
\n<\/span><\/p>\n

88. Opioid hypersensitivity: predictors of allergy and role of drug provocation testing
\n<\/span>Li PH<\/b>, KL Ue, Wagner A, Rutkowski R, Rutkowski K.
\nJ Allergy Clin Immunol Pract.<\/i> 2017 Nov – Dec;5(6):1601-1606. doi: 10.1016\/j.jaip.2017.03.035.
\n<\/span><\/p>\n

89. Immunoglobulin G4-related disease in Hong Kong: clinical features, treatment practices and associations
\n<\/span>Li PH<\/b>, Ko KL, Ho CTK, Lau LL, Tsang RKY, Cheung TT, Leung WK, Lau CS.
\nHong Kong Med J.<\/i> 2017 Oct;23(5):446-53. doi: 10.12809\/hkmj176229.
\n<\/span><\/p>\n

90. Occupational allergic contact dermatitis due to multiple tropical plant species
\n<\/span>Watts TJ, Li PH<\/b>, Thomas I, Haque R.
\nJ Allergy Clin Immunol Pract. <\/i>2017 Sep – Oct;5(5):1411-1412. doi: 10.1016\/j.jaip.2017.04.02.
\n<\/span><\/p>\n

91. Sesame allergy in adults: Investigation and outcomes of oral food challenges
\n<\/span>Li PH<\/b>, Gunawardana N, Thomas I, Ue KL, Siew L, Watts TJ, Bintcliffe K, Haque R, Rutkowski K, Skypala I, Till SJ.
\nAnn Allergy Asthma Immunol.<\/i> 2017 Sep;119(3):285-287. doi: 10.1016\/j.anai.2017.06.013.
\n<\/span><\/p>\n

92. Immunoglobulin G testing in the diagnosis of food allergy and intolerance
\n<\/span>Lee TH, Wu YY, Chan JKC, Ho HK, Li PH<\/b>, Rosa JS.
\nHong Kong Med J. <\/i>2017 Aug;23(4):419\u201320. doi: 10.12809\/hkmj176310.
\n<\/span><\/p>\n

93. Immunology in Food Allergy and Anaphylaxis
\n<\/span>Li PH<\/b>, Lau CS.
\nHong Kong Bulletin on Rheumatic Diseases <\/i>2017 Jul;17(1):26-28. doi: 10.1515\/hkbrd-2017-0004.<\/span><\/p>\n

94. Secondary antibody deficiency and immunoglobulin replacement
\n<\/span>Li PH<\/b>, Lau CS.
\nHong Kong Bulletin on Rheumatic Diseases<\/i> 2017 Jul;17(1):1-5. doi: 10.1515\/hkbrd-2017-0001.
\n<\/span><\/p>\n

95. Vaccine allergy: A decade of experience from 2 large UK allergy centers
\n<\/span>Li PH<\/b>, Wagner A, Rutkowski R, Rutkowski K.
\nAnn Allergy Asthma Immunol. <\/i>2017 Jun;118(6):729-731. doi: 10.1016\/j.anai.2017.03.010.
\n<\/span><\/p>\n

96. Anaphylaxis to tranexamic acid\u2014a rare reaction to a common drug
\n<\/span>Li PH<\/b>, Trigg C, Rutkowski R, Rutkowski K.
\nJ Allergy Clin Immunol Pract. <\/i>2017 May – Jun;5(3):839-841. doi: 10.1016\/j.jaip.2016.12.014.
\n<\/span><\/p>\n

97. Lupus in the Far East: a modern epidemic
\n<\/span>Li PH<\/b>, Lau CS.
\nInt J Rheum Dis<\/i>. 2017 May;20(5):523-525. doi: 10.1111\/1756-185X.13115.
\n<\/span><\/p>\n

98. Epidemiology and clinical characteristics of Acinetobacter<\/i> peritoneal dialysis-related peritonitis in Hong Kong – with a perspective on multi-drug and carbapenem resistance
\n<\/span>Li PH<\/b>, Cheng VC, Yip T, Yap DY, Lui SL, Lo WK.
\nPerit Dial Int<\/i>. 2017 Mar-Apr;37(2):177-182. doi: 10.3747\/pdi.2016.00123.
\n<\/span><\/p>\n

99. Comparing diffusion weighted imaging with clinical and blood parameters, and with short tau inversion recovery sequence in detecting spinal and sacroiliac joint inflammation in axial spondyloarthritis
\n<\/span>Chung HY, Xu X, Lau VWH, Ho G, Lee KL, Li PH<\/b>, Tsang HHL, Kwok SK, Lau CS, Wong CS.
\nClin Exp Rheumatol. <\/i>2017 Mar-Apr;35(2):262-269.
\n<\/span><\/p>\n

100. The effects of AIDS on the prevalence of rheumatic diseases
\n<\/span>Lau CS, Li PH<\/b>.
\nNat Rev Rheumatol.<\/i> 2017 Jan;13(1):8-10. doi: 10.1038\/nrrheum.2016.196.
\n<\/span><\/p>\n

101. Melioidosis mycotic aneurysm: An uncommon complication of an uncommon disease
\n<\/span>Li PH<\/b>, Chau CH, Wong PC.<\/span>
\n<\/span>Respir Med Case Rep. <\/i>2014 Dec 29;14:43-6. doi: 10.1016\/j.rmcr.2014.12.005<\/span><\/p>\n

102. Relationship between autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong Kong Chinese<\/span>
\nLi PH<\/b>, Wong WH, Lee TL, Lau CS, Chan TM, Leung AM, Tong KL, Tse NK, Mok CC, Wong SN, Lee KW, Ho MH, Lee PP, Chong CY, Wong RW, Mok MY, Ying SK, Fung SK, Lai WM, Yang W, Lau YL.
\nRheumatology (Oxford).<\/i> 2013 Feb;52(2):337-45. doi: 10.1093\/rheumatology\/kes261.
\n<\/span><\/p>\n

103. Association of CD247 with systemic lupus erythematosus in Asian populations
\n<\/span>Li R, Yang W, Zhang J, Hirankarn N, Pan HF, Mok CC, Chan TM, Wong RW, Mok MY, Lee KW, Wong SN, Leung AM, Li XP, Avihingsanon Y, Lee TL, Ho MH, Lee PP, Wong WH, Wong CM, Ng IO, Yang J, Li PH<\/b>, Zhang Y, Zhang L, Li W, Baum L, Kwan P, Rianthavorn P, Deekajorndej T, Suphapeetiporn K, Shotelersuk V, Garcia -Barcel\u00f3 MM, Cherny SS, Tam PK, Sham PC, Lau CS, Shen N, Lau Yl, Ye DQ.
\nLupus. <\/i>2012 Jan;21(1):75-83. doi: 10.1177\/0961203311422724.
\n<\/span><\/p>\n

104. Lack of Association of TYK2 Gene Polymorphisms in Chinese Patients with Systemic Lupus Erythematosus
\n<\/span>Li PH<\/b>, Chang YK, Shek KW, Lau YL.
\nJ Rheumatol<\/i>. 2011 Jan;38(1):177-8. doi: 10.3899\/jrheum.100424.
\n<\/span><\/p>\n

105. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with Systemic Lupus Erythematosus<\/span>
\nYang W, Shen N, Ye DQ, Liu Q, Zhang Y, Qian XX, Hirankarn N, Ying D, Pan HF, Mok CC, Chan TM, Wong RW, Lee KW, Mok MY, Wong SN, Leung AM, Li XP, Avihingsanon Y, Wong CM, Lee TL, Ho MH, Lee PP, Chang YK,
\nLi PH<\/b>, Li RJ, Zhang L, Wong WH, Ng IO, Lau CS, Sham PC, Lau YL.
\nPLoS Genet<\/i>. 2010 Feb 12;6(2):e1000841. doi: 10.1371\/journal.pgen.1000841.<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":1670,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"inline_featured_image":false,"footnotes":""},"acf":[],"_links":{"self":[{"href":"https:\/\/immune.hku.hk\/en\/wp-json\/wp\/v2\/pages\/3383"}],"collection":[{"href":"https:\/\/immune.hku.hk\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/immune.hku.hk\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/immune.hku.hk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/immune.hku.hk\/en\/wp-json\/wp\/v2\/comments?post=3383"}],"version-history":[{"count":4,"href":"https:\/\/immune.hku.hk\/en\/wp-json\/wp\/v2\/pages\/3383\/revisions"}],"predecessor-version":[{"id":3461,"href":"https:\/\/immune.hku.hk\/en\/wp-json\/wp\/v2\/pages\/3383\/revisions\/3461"}],"up":[{"embeddable":true,"href":"https:\/\/immune.hku.hk\/en\/wp-json\/wp\/v2\/pages\/1670"}],"wp:attachment":[{"href":"https:\/\/immune.hku.hk\/en\/wp-json\/wp\/v2\/media?parent=3383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}